16/03/2006 (Agence Europe) - Six volunteers taking part in clinical trials have been hospitalised in north-west London following severe anaphylactic shock. Their condition was described as critical on Wednesday 15 March due to severe organ failure. An inquiry is underway to determine whether the product injected or the trial protocol should be incriminated. The product had received the status of orphan medicine in April 2005 from the European Agency on the Evaluation of Medicinal Products...